Personalized medicine - A tailored health care system: Challenges and opportunities

Croatian Medical Journal

Volumn 53, Issue 3, 2012, Pages 211-213

  Louca, Soulla ^a  

^a UNIVERSITY OF NICOSIA   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICINE; COMPUTER PROGRAM; DRUG DEVELOPMENT; DRUG INDUSTRY; EPIGENETICS; EVIDENCE BASED MEDICINE; GENOMICS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; INTERDISCIPLINARY RESEARCH; INTERNET; NANOBIOTECHNOLOGY; PATIENT CARE; PERSONALIZED MEDICINE; SIMULATION; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; EUROPE; GENETIC TESTING; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84866438177     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.211     Document Type: Article

References (14)

1. Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. Genomic medicine: past, present and future. Genome Med. 2011;3:6. Medline:21345269 doi:10.1186/gm220
2. COST foresight workshop report. Benefitting from the digital revolution. Workshop on life enhancement. Available from: http:// www.cost.eu/module/download/7943. Accessed: May 22, 2012.
3. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363:301-4. Medline:20551152 doi:10.1056/ NEJMp1006304
4. European Commission-Information Society and Media. European challenges and flagships: 2020 and beyond. Report of the ICT Advisory Group (ISTAG). Available from http://www.umic.pt/ images/stories/publicacoes4/press-17_en.pdf. Accessed: May 22, 2012.
5. European Commission - future and emerging technologies, moving the ICT frontiers a strategy for research on future and emerging technologies in Europe. Available from http://ec.europa. eu/information_society/events/fet/2009/documents/fetcom.pdf. Accessed: May 22, 2012.
6. Innovateuk. Stratified medicine: A UK vision for stratified medicine, Available from: http://www.innovateuk.org/ourstrategy/ innovationplatforms/stratified-medicine-.ashx. Accessed: May 22, 2012.
7. Biobanks. The Swedish Biobank Program. Available from: http:// www.biobanks.se/. Accessed: May 22, 2012.
8. Biomedreg. Objectives. Available from: http://www.biomedreg.eu/ en/about-project/objectives. Accessed: May 22, 2012.
9. Bio-m. Available from: http://www.bio-m.org/en/index.html. Accessed: May 22, 2012.
10. Težak Ž, Kondratovich MV, Mansfield EUS. FDA and personalized medicine: In vitro diagnostic regulatory perspective. Personalized Medicine. 2010;7:517-30. doi:10.2217/pme.10.53
11. Hudson KL. Genomics, health care, and society. N Engl J Med. 2011;365:1033-41. Medline:21916641 doi:10.1056/NEJMra1010517
12. What happened to personalized medicine? Nat Biotechnol. 2012;30:1. Medline:22231070 doi:10.1038/nbt.2096
13. Blair ED, Clarke BR, O'Neill T. Sustaining development of stratified medicines in the UK healthcare system: a commentary. Personalized Medicine. 2011;8:517-21. doi:10.2217/pme.11.50
14. Knowles J. European perspectives in personalised medicine - opportunities and challenges. Available from: http://ec.europa.eu/ research/health/pdf/event06/12052011/jonathan-knowles_en.pdf. Accessed: May 22, 2012.